Hyperglycemia at hospital admission for acute myocardial infarction (AMI) may indicate developing or unrecognized diabetes in patients with no history of the condition, according to a new study.
A nurse-delivered phone coaching initiative that aimed to improve outpatients' glycemic control wasn't more successful than usual care, a new study found.
Stepwise prandial insulin intensification provided glycemic control that was non-inferior to a full basal-bolus regimen after 32 weeks, with significantly lower hypoglycemia risk and better patient satisfaction, an industry-funded study found.
This month's quiz asks readers to evaluate a 56-year-old man who received a diagnosis of type 2 diabetes mellitus 6 months ago and is returning for follow up.
Researchers created a new score, based on four variables, which can help predict whether a patient will have remission of type 2 diabetes after Roux-en-Y gastric bypass surgery.
Intensive use of insulin to regulate hyperglycemia in acute coronary syndrome (ACS) patients did not reduce infarct size, and may have caused harm, a new study found.
Patients with type 1 diabetes and documented nocturnal hypoglycemia who were randomized to receive sensor-enhanced insulin pump therapy with a threshold-suspend feature had reduced nocturnal hypoglycemia and no difference in glycated hemoglobin levels compared to those on sensor-augmented insulin pump therapy alone, a recent study found.
The annual meeting of the European Association for the Study of Diabetes was held in Barcelona, Spain in September. Research presented at the meeting covered risks of sulfonylureas, pioglitazone and macular edema, treatment intensification and erectile dysfunction.